PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Ifosfamide

Subscribe to Selected New Research on Ifosfamide

2261 relevant articles (238 outcomes, 782 trials/studies) found for this Drug

Description: Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent.

Also Known As:

Asta Z 4942; Holoxan; Iphosphamide; Iso-Endoxan; NSC-109,724; NSC-109724; Iso Endoxan; NSC 109,724; NSC 109724; NSC109,724; NSC109724; Isofosfamide; Isophosphamide; 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide

Relationship Network

Drug Context: Research Results

-

Organic Chemicals: 40

-

Hydrocarbons: 382

-

Halogenated Hydrocarbons: 28

-

Mustard Compounds: 3

-

Nitrogen Mustard Compounds: 1

-

Phosphoramide Mustards: 3

-

Cyclophosphamide: 14977

-

Ifosfamide: 2261

*

ICE protocol 1: 8

*

beta-D-glucosylisophosphoramide mustard: 6

*

hydroperoxyisophosphamide: 6

*

4-hydroxyifosfamide: 5

*

*

bromofosfamide: 4

*

chlorobromofosfamide: 3

*

MINE regimen: 3

*

VIP protocol 2: 3

*

IAP protocol: 2

*

CAMBO-VIP protocol: 1

*

COSS-86 protocol: 1

*

FIM protocol: 1

*

HOP protocol: 1

*

ICE protocol 3: 1

*

*

IEV protocol: 1

*

*

IVAD protocol: 1

*

MAMI protocol: 1

*

MICE regimen: 1

*

MINE protocol: 1

*

*

*

OS 87 protocol: 1

*

PAVI protocol: 1

*

SSG IX protocol: 1

*

VIA protocol: 1

*

VIM-Bleo protocol: 1

*

4-ketoifosfamide

*

acetaldoifosphamide

*

*

*

*

*

carboxyifosfamide

*

CEOP-IMVP-Dexa regimen

*

*

*

*

dechloroethylifosfamide

*

*

*

*

ENSG 3C protocol

*

*

*

*

G-IDEA protocol

*

*

*

*

*

*

*

*

*

*

IMVP-16 protocol

*

*

*

*

*

*

*

*

MCP 842 regimen

*

*

MINE-BOP protocol

*

MINE-ESHAP protocol

*

*

*

*

N-dechloroethylifosfamide

*

*

PETHEMA ALL-3-97 protocol

*

phenylketoisophosphamide

*

*

*

*

*

Rizzoli IOR protocol

*

*

VACIME protocol

*

*

*

*

*

*

*

*

*

*

VIM3-ARA C regimen

*

*

*

*

*

*

-

Organophosphorus Compounds: 126

-

Phosphoramide Mustards: 3

-

Cyclophosphamide: 14977

-

Ifosfamide: 2261

*

ICE protocol 1: 8

*

beta-D-glucosylisophosphoramide mustard: 6

*

hydroperoxyisophosphamide: 6

*

4-hydroxyifosfamide: 5

*

*

bromofosfamide: 4

*

chlorobromofosfamide: 3

*

MINE regimen: 3

*

VIP protocol 2: 3

*

IAP protocol: 2

*

CAMBO-VIP protocol: 1

*

COSS-86 protocol: 1

*

FIM protocol: 1

*

HOP protocol: 1

*

ICE protocol 3: 1

*

*

IEV protocol: 1

*

*

IVAD protocol: 1

*

MAMI protocol: 1

*

MICE regimen: 1

*

MINE protocol: 1

*

*

*

OS 87 protocol: 1

*

PAVI protocol: 1

*

SSG IX protocol: 1

*

VIA protocol: 1

*

VIM-Bleo protocol: 1

*

4-ketoifosfamide

*

acetaldoifosphamide

*

*

*

*

*

carboxyifosfamide

*

CEOP-IMVP-Dexa regimen

*

*

*

*

dechloroethylifosfamide

*

*

*

*

ENSG 3C protocol

*

*

*

*

G-IDEA protocol

*

*

*

*

*

*

*

*

*

*

IMVP-16 protocol

*

*

*

*

*

*

*

*

MCP 842 regimen

*

*

MINE-BOP protocol

*

MINE-ESHAP protocol

*

*

*

*

N-dechloroethylifosfamide

*

*

PETHEMA ALL-3-97 protocol

*

phenylketoisophosphamide

*

*

*

*

*

Rizzoli IOR protocol

*

*

VACIME protocol

*

*

*

*

*

*

*

*

*

*

VIM3-ARA C regimen

*

*

*

*

*

*

-

Heterocyclic Compounds: 23

-

1-Ring Heterocyclic Compounds

-

-

Ifosfamide: 2261

*

ICE protocol 1: 8

*

beta-D-glucosylisophosphoramide mustard: 6

*

hydroperoxyisophosphamide: 6

*

4-hydroxyifosfamide: 5

*

*

bromofosfamide: 4

*

chlorobromofosfamide: 3

*

MINE regimen: 3

*

VIP protocol 2: 3

*

IAP protocol: 2

*

CAMBO-VIP protocol: 1

*

COSS-86 protocol: 1

*

FIM protocol: 1

*

HOP protocol: 1

*

ICE protocol 3: 1

*

*

IEV protocol: 1

*

*

IVAD protocol: 1

*

MAMI protocol: 1

*

MICE regimen: 1

*

MINE protocol: 1

*

*

*

OS 87 protocol: 1

*

PAVI protocol: 1

*

SSG IX protocol: 1

*

VIA protocol: 1

*

VIM-Bleo protocol: 1

*

4-ketoifosfamide

*

acetaldoifosphamide

*

*

*

*

*

carboxyifosfamide

*

CEOP-IMVP-Dexa regimen

*

*

*

*

dechloroethylifosfamide

*

*

*

*

ENSG 3C protocol

*

*

*

*

G-IDEA protocol

*

*

*

*

*

*

*

*

*

*

IMVP-16 protocol

*

*

*

*

*

*

*

*

MCP 842 regimen

*

*

MINE-BOP protocol

*

MINE-ESHAP protocol

*

*

*

*

N-dechloroethylifosfamide

*